Squarepoint Ops LLC Applied Genetic Technologies Corp Transaction History

Squarepoint Ops LLC

  • $62.8 Billion
  • Q3 2024

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
SELL
$1.07 - $2.71 $16,358 - $41,430
-15,288 Closed
0 $0
Q4 2021

Feb 14, 2022
SELL
$1.87 - $2.91 $79,001 - $122,938
-42,247 Reduced 73.43%
15,288 $29,000
Q3 2021

Nov 15, 2021
SELL
$3.01 - $4.12 $287,725 - $393,830
-95,590 Reduced 62.43%
57,535 $173,000
Q2 2021

Aug 16, 2021
BUY
$3.62 - $5.23 $232,729 - $336,236
64,290 Added 72.37%
153,125 $599,000
Q1 2021

May 17, 2021
BUY
$3.94 - $8.19 $101,388 - $210,753
25,733 Added 40.78%
88,835 $450,000
Q4 2020

Feb 16, 2021
SELL
$3.99 - $5.7 $181,860 - $259,800
-45,579 Reduced 41.94%
63,102 $258,000
Q3 2020

Nov 16, 2020
BUY
$4.38 - $6.43 $62,568 - $91,852
14,285 Added 15.13%
108,681 $528,000
Q2 2020

Aug 14, 2020
SELL
$3.0 - $6.9 $113,544 - $261,151
-37,848 Reduced 28.62%
94,396 $523,000
Q1 2020

May 15, 2020
BUY
$2.36 - $9.86 $101,154 - $422,619
42,862 Added 47.95%
132,244 $434,000
Q4 2019

Feb 14, 2020
SELL
$2.69 - $4.92 $11,884 - $21,736
-4,418 Reduced 4.71%
89,382 $404,000
Q3 2019

Nov 14, 2019
BUY
$2.59 - $4.16 $70,639 - $113,459
27,274 Added 41.0%
93,800 $390,000
Q2 2019

Aug 14, 2019
BUY
$3.6 - $4.78 $187,552 - $249,028
52,098 Added 361.09%
66,526 $252,000
Q1 2019

May 15, 2019
BUY
$2.62 - $4.44 $37,801 - $64,060
14,428 New
14,428 $60,000
Q2 2018

Aug 14, 2018
SELL
$3.7 - $5.65 $51,060 - $77,970
-13,800 Closed
0 $0
Q1 2018

May 15, 2018
SELL
$3.65 - $5.2 $11,315 - $16,120
-3,100 Reduced 18.34%
13,800 $53,000
Q4 2017

Feb 14, 2018
SELL
$3.4 - $4.15 $97,920 - $119,520
-28,800 Reduced 63.02%
16,900 $61,000
Q3 2017

Nov 14, 2017
BUY
$3.55 - $5.25 $162,235 - $239,925
45,700
45,700 $181,000

About APPLIED GENETIC TECHNOLOGIES CORP

AGTC Quotes by TradingView
  • Ticker AGTC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 67,632,200
  • Description
  • Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. Its advanced product candidates include three ophthalmology development programs across two targets, including X-linked retinitis pigmentosa, which is in the Pha...
More about AGTC
Track This Portfolio

Track Squarepoint Ops LLC Portfolio

Follow Squarepoint Ops LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email